Blueprint Medicines Corp (BPMC) Transcripts
Q3 2024 Blueprint Medicines Corp Earnings Call Transcript
Oct 30, 2024
$89.24
(+7.00%)
Earnings
Q2 2024 Blueprint Medicines Corp Earnings Call Transcript
Aug 01, 2024
$100.29
(-7.40%)
Earnings
Q1 2024 Blueprint Medicines Corp Earnings Call Transcript
May 02, 2024
$107
(+12.80%)
Earnings
Q4 2023 Blueprint Medicines Corp Earnings Call Transcript
Feb 15, 2024
$87.57
(+14.02%)
Earnings
Blueprint Medicines Corp at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Q3 2023 Blueprint Medicines Corp Earnings Call Transcript
Oct 26, 2023
$55.22
(+25.61%)
Earnings
Blueprint Medicines Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Q2 2023 Blueprint Medicines Corp Earnings Call Transcript
Aug 02, 2023
$54.3
(-15.34%)
Earnings
Blueprint Medicines Corp at Goldman Sachs Healthcare Conference Transcript
Jun 14, 2023
Blueprint Medicines Corp To Discuss The FDA Approval of AYVAKIT in ISM Call Transcript
May 22, 2023
Q1 2023 Blueprint Medicines Corp Earnings Call Transcript
May 04, 2023
$58.41
(+12.59%)
Earnings
Blueprint Medicines Corp at Stifel Targeted Oncology Days (Virtual) Transcript
Apr 25, 2023
Blueprint Medicines Corp at Barclays Global Healthcare Conference Transcript
Mar 15, 2023
Blueprint Medicines Corp To Discuss The Registrational PIONEER Trial Data Of AYVAKIT In Indolent SM Call Transcript
Feb 27, 2023
Q4 2022 Blueprint Medicines Corp Earnings Call Transcript
Feb 16, 2023
$44.71
(+1.54%)
Earnings
Blueprint Medicines Corp at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q3 2022 Blueprint Medicines Corp Earnings Call & Investor Day Transcript
Nov 01, 2022
$48.24
(-6.94%)
Earnings
Blueprint Medicines Corporate call Transcript
Aug 17, 2022
Q2 2022 Blueprint Medicines Corp Earnings Call Transcript
Aug 02, 2022
$56.29
(+11.25%)
Earnings
Blueprint Medicines Corp Collaborations with Sixth Street and Royalty Pharma - Corporate Call Transcript
Jun 30, 2022
Blueprint Medicines Corp at JMP Securities Life Sciences Conference (Virtual) Transcript
Jun 16, 2022
Blueprint Medicines Corp at Goldman Sachs Global Healthcare Conference Transcript
Jun 16, 2022
Q1 2022 Blueprint Medicines Corp Earnings Call Transcript
May 03, 2022
$62.82
(+5.19%)
Earnings
Blueprint Medicines Corp Call to Discuss Data Reported at AACR Transcript
Apr 08, 2022
Blueprint Medicines Corp at Cowen Health Care Conference (Virtual) Transcript
Mar 08, 2022
Q4 2021 Blueprint Medicines Corp Earnings Call Transcript
Feb 16, 2022
$74.9
(-9.99%)
Earnings
Blueprint Medicines Corp to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics Inc Call Transcript
Nov 29, 2021
Q3 2021 Blueprint Medicines Corp Earnings Call Transcript
Oct 28, 2021
$113.33
(+8.75%)
Earnings
Blueprint Medicines Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 09, 2021
Q2 2021 Blueprint Medicines Corp Earnings Call Transcript
Jul 29, 2021
$84.74
(+2.21%)
Earnings
Blueprint Medicines Corp Corporate Call to Discuss the FDA Approval of AYVAKIT in Advanced SM Transcript
Jun 16, 2021
Blueprint Medicines Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021
Blueprint Medicines Corp Annual Shareholders Meeting Transcript
Jun 02, 2021
Q1 2021 Blueprint Medicines Corp Earnings Call Transcript
Apr 29, 2021
$98.87
(+1.66%)
Earnings
Blueprint Medicines Corp AACR Conference Call Transcript
Apr 12, 2021
Blueprint Medicines Corp at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 10, 2021
Q4 2020 Blueprint Medicines Corp Earnings Call Transcript
Feb 17, 2021
$100.25
(+7.56%)
Earnings
Q3 2020 Blueprint Medicines Corp Earnings Call Transcript
Oct 29, 2020
$106.84
(+2.11%)
Earnings
Blueprint Medicines Corp Advanced Systemic Mastocytosis Topline Data Call Transcript
Sep 22, 2020
Blueprint Medicines Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Blueprint Medicines Corp to Discuss the FDA Approval of GAVRETO Conference Call Transcript
Sep 08, 2020
Q2 2020 Blueprint Medicines Corp Earnings Call Transcript
Jul 30, 2020
$73.89
(+0.19%)
Earnings
Blueprint Medicines Corp to Discuss the Global Collaboration with Roche to Develop and Commercialize Pralsetinib for Patients with RET-Altered Cancers Call Transcript
Jul 14, 2020
Blueprint Medicines Corp Annual Shareholders Meeting Transcript
Jun 23, 2020
Blueprint Medicines Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2020
Blueprint Medicines Corp ASCO20 Conference Call Transcript
May 29, 2020
Q1 2020 Blueprint Medicines Corp Earnings Call Transcript
May 06, 2020
$58.97
(-1.29%)
Earnings
Blueprint Medicines Corp VOYAGER Corporate Call Transcript
Apr 28, 2020
Blueprint Medicines Corp AAAAI Call Transcript
Mar 16, 2020
Q4 2019 Blueprint Medicines Corp Earnings Call Transcript
Feb 13, 2020
$63.81
(-1.44%)
Earnings
Blueprint Medicines Corp AYVAKITâ„¢ FDA Approval Conference Call Transcript
Jan 09, 2020
Blueprint Medicines Corp to Host Investor Event and Webcast to Review Initial Data from the PIONEER Trial Presented at ASH Transcript
Dec 09, 2019
Blueprint Medicines Corp Research and Development Day with Q3 2019 Blueprint Medicines Corp Earnings Call Transcript
Nov 05, 2019
$70.5
(+5.04%)
Earnings
Blueprint Medicines Corp at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019
Q2 2019 Blueprint Medicines Corp Earnings Call Transcript
Aug 01, 2019
$93.82
(-6.32%)
Earnings
Blueprint Medicines Corp Presents Updated EXPLORER Trial Data for Avapritinib in Patients with Systemic Mastocytosis at 24th EHA Congress Transcript
Jun 17, 2019
Blueprint Medicines Corp at Goldman Sachs Global Healthcare Conference Transcript
Jun 12, 2019
Blueprint Medicines Corp ASCO 2019 Analyst and Investor Reception Transcript
Jun 03, 2019
Blueprint Medicines Corp at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019
Q1 2019 Blueprint Medicines Corp Earnings Call Transcript
May 09, 2019
$82.3
(+7.22%)
Earnings
Blueprint Medicines Corp at Cowen Health Care Conference Transcript
Mar 12, 2019
Q4 2018 Blueprint Medicines Corp Earnings Call Transcript
Feb 26, 2019
$76.42
(-1.56%)
Earnings